Yusen Logistics opens Pharma Gateway at Schiphol

Yusen Logistics opens Pharma Gateway at Schiphol

Yusen Logistics has opened a dedicated Pharma Gateway at Amsterdam Airport Schiphol.

This new operation represents the launch of Yusens’ good distribution practice (GDP) compliant global pharma airfreight services, the latest step in the company’s customer-driven development in the pharmaceutical supply chain.

The official opening ceremony was performed by president of Yusen, Hiromitsu Kuramoto, who was joined by Yusen colleagues in welcoming guests including customers, airport officials and customs authorities at the inauguration event.

Kuramoto says: “This opening represents the next step in the realisation of our global healthcare strategy, with this strategic European operation at its very heart. Yusen Logistics Europe is playing an outstanding and important role in leading our global business in this sector. I am very much honored to be here today, on the occasion of this key milestone.

“As we make this important step today, I confirm Yusen Logistics’ commitment to further developing and improving our services to the healthcare sector. We shall work to support and maintain our strong relationships with our pharmaceutical manufacturer customers into the future, as they continue to develop ever more sophisticated products.

“I would like to take this opportunity to sincerely thank them all for entrusting us with their products. We never forget that at the end of the supply chain, there is a patient.”

Amsterdam Airport Schiphol Cargo director for business development, Bart Pouwels, welcomed the
opening of the pharma facility at Schiphol. “We are delighted that they have added to Schiphol’s collective pharma capability with this significant investment, and that they have identified the strong advantages of Schiphol as the ideal location for their hub.

“Schiphol’s global network, frequency of service, choice of carrier, streamlined handling processes and supportive Customs are all part of its unique pharma offering. Yusen is now positioned to take full advantage of these factors in developing its global pharma product.”

This new operation has been developed in close consultation with Yusen Logistics’ pharma customers, who are increasingly looking for new ways to optimise flows within the constraints of GDP. It links Yusen’s Antwerp import/export consolidation centre and European central warehouse with its Schiphol air operations, to form a multi-modal hub.

This is managed from a single control tower, manned by a UK based international team linked to Yusen Logistics’ offices around the world.

Customers can now call off full or part load consignments for movement by air, sea or road through Yusen Logistics European Pharmaceutical Superhighway.

Yusen says it gives it the flexibility to create efficiencies, driving out cost, providing value to customers in this highly demanding environment.

The European Pharmaceutical Superhighway is contracted to carry over 1.6 million pallets this year, providing shared and single use solutions to highly complex supply chain requirements for our customers.

The service is dedicated solely to the stringent requirements of the pharmaceutical and healthcare industry, with over 50,000 delivery points in Europe alone. Yusen is currently making 20,000 deliveries per week across 36 countries.

Picture of James Graham

James Graham

James Graham is an award-winning transport media journalist with a long background in the commercial freight sector, including commercial aviation and the aviation supply chain. He was the initial Air Cargo Week journalist and retuned later for a stint as editor. He continues his association as editor of the monthly supplements. He has reported for the newspaper from global locations as well as the UK.

Newsletter

Stay informed. Stay ahead. To get the latest air cargo news and industry trends delivered directly to your inbox, sign up now!

related articles

IAG Cargo appoints head of digital sales

Reopening Ukrainian Airports: Lviv and Boryspil in Focus

Avolon upsizes credit facility to $5.8 billion